Broadcom Inc (NASDAQ: AVGO) Has Another Chance To Impress You

Currently, there are 4.69B common shares owned by the public and among those 4.59B shares have been available to trade.

The company’s stock has a 5-day price change of -3.31% and 20.63% over the past three months. AVGO shares are trading -3.25% year to date (YTD), with the 12-month market performance up to 107.22% higher. It has a 12-month low price of $106.26 and touched a high of $251.88 over the same period. AVGO has an average intraday trading volume of 28.31 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.43%, 15.87%, and 37.16% respectively.

Institutional ownership of Broadcom Inc (NASDAQ: AVGO) shares accounts for 75.85% of the company’s 4.69B shares outstanding.

It has a market capitalization of $1051.42B and a beta (3y monthly) value of 1.05. The stock’s trailing 12-month PE ratio is 184.00, while the earnings-per-share (ttm) stands at $1.22. The company has a PEG of 8.68 and a Quick Ratio of 1.07 with the debt-to-equity ratio at 1.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.59% over the week and 4.56% over the month.

Earnings per share for the fiscal year are expected to increase by 30.32%, and 20.26% over the next financial year. EPS should grow at an annualized rate of 21.20% over the next five years, compared to 13.91% over the past 5-year period.

Looking at the support for the AVGO, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on December 13, 2024, with the firm’s price target at $210-$240. Mizuho coverage for the Broadcom Inc (AVGO) stock in a research note released on October 14, 2024 offered a Outperform rating with a price target of $220. William Blair was of a view on September 18, 2024 that the stock is Outperform, while TD Cowen gave the stock Buy rating on July 16, 2024, issuing a price target of $175- $210. Rosenblatt on their part issued Buy rating on July 11, 2024.

Most Popular

Related Posts